Novolog 100 unit/ML flexpen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F8Y9W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,021
Award facts
- Contract value 100% obligated
- $1,020.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,020.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on January 15, 2026, with completion scheduled for January 16, 2026. The award was made on a non-set-aside, competitive basis to the Conshohocken, Pennsylvania-based pharmaceutical distributor. This delivery order represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s, significantly larger indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in the military medical supply chain, delivering a diverse range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. The company's ability to fulfill this insulin order reflects its established capability to efficiently meet federal procurement requirements for essential medications supporting military treatment facilities and veterans' healthcare programs. The small transaction value and rapid completion timeline are typical of routine pharmaceutical resupply orders processed under the larger DLA framework.
Quick answers
Who was awarded contract SPE2DR26F8Y9W?
SPE2DR26F8Y9W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F8Y9W worth?
The government has obligated $1,021 on SPE2DR26F8Y9W.
Is contract SPE2DR26F8Y9W an order under another contract?
Yes. SPE2DR26F8Y9W is a delivery order under SPE2DR25D1107, an indefinite delivery contract.
Was contract SPE2DR26F8Y9W competed?
The extent of competition for SPE2DR26F8Y9W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award